DE60310744D1 - Reihentestverfahren auf moleküle mit anti-prionaktivität: kits, methoden und moleküle - Google Patents

Reihentestverfahren auf moleküle mit anti-prionaktivität: kits, methoden und moleküle

Info

Publication number
DE60310744D1
DE60310744D1 DE60310744T DE60310744T DE60310744D1 DE 60310744 D1 DE60310744 D1 DE 60310744D1 DE 60310744 T DE60310744 T DE 60310744T DE 60310744 T DE60310744 T DE 60310744T DE 60310744 D1 DE60310744 D1 DE 60310744D1
Authority
DE
Germany
Prior art keywords
molecules
kits
methods
test procedure
antiprion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310744T
Other languages
English (en)
Other versions
DE60310744T2 (de
Inventor
Marc Blondel
Stephane Bach
Christophe Cullin
Nicolas Talarek
Jean-Michel Vierfond
Yvette Mettey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Universite de Poitiers
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Universite de Poitiers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0213022A external-priority patent/FR2846008B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Victor Segalen Bordeaux 2, Universite de Poitiers filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE60310744D1 publication Critical patent/DE60310744D1/de
Application granted granted Critical
Publication of DE60310744T2 publication Critical patent/DE60310744T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE60310744T 2002-10-18 2003-10-20 Reihentestverfahren auf moleküle mit anti-prionaktivität: kits, methoden und moleküle Expired - Lifetime DE60310744T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0213022 2002-10-18
FR0213022A FR2846008B1 (fr) 2002-10-18 2002-10-18 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
FR0308289 2003-07-07
FR0308289A FR2846009B1 (fr) 2002-10-18 2003-07-07 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
PCT/FR2003/003101 WO2004035813A2 (fr) 2002-10-18 2003-10-20 Criblage de molecules a activite anti-prion : kits, methodes et molecules criblees

Publications (2)

Publication Number Publication Date
DE60310744D1 true DE60310744D1 (de) 2007-02-08
DE60310744T2 DE60310744T2 (de) 2007-10-11

Family

ID=32071174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310744T Expired - Lifetime DE60310744T2 (de) 2002-10-18 2003-10-20 Reihentestverfahren auf moleküle mit anti-prionaktivität: kits, methoden und moleküle

Country Status (10)

Country Link
US (4) US8129402B2 (de)
EP (1) EP1551992B1 (de)
JP (1) JP4529030B2 (de)
AT (1) ATE349550T1 (de)
AU (1) AU2003285413A1 (de)
CA (1) CA2502544C (de)
DE (1) DE60310744T2 (de)
ES (1) ES2279975T3 (de)
FR (1) FR2846009B1 (de)
WO (1) WO2004035813A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1908465B1 (de) * 2006-10-04 2009-04-29 Centre National De La Recherche Scientifique (Cnrs) Chlor enthaltende Guanabenz Derivate zur Behandlung von Prionerkrankungen
CN101481729B (zh) * 2009-01-21 2014-04-16 辽宁大学 一种高灵敏度的利用基因突变酵母细胞筛选抗朊病毒药物的方法
WO2018073321A1 (en) 2016-10-18 2018-04-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
DE2430380C3 (de) * 1974-06-25 1980-04-30 Behringwerke Ag, 3550 Marburg Herstellung eines Stoffes mit immunologischer Wirkung
JPH0262826A (ja) * 1988-08-30 1990-03-02 Sawai Seiyaku Kk 成人ｔ細胞白血病治療剤
EP0565491A1 (de) * 1992-04-10 1993-10-13 Dornag Ag Kupplungsvorrichtung, insbesondere zur Kupplung eines Werkzeughalters mit einer Antriebswelle
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US7799535B1 (en) * 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
BR9914385A (pt) * 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
WO2000076982A1 (en) 1999-06-16 2000-12-21 University Of Iowa Research Foundation Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
EP1392849B2 (de) * 2001-02-15 2012-01-18 University Of Chicago Verfahren zum nachweis in hefe für mittel die proteinfaltung beeinflussen

Also Published As

Publication number Publication date
US20120122916A1 (en) 2012-05-17
EP1551992B1 (de) 2006-12-27
US8129402B2 (en) 2012-03-06
WO2004035813A2 (fr) 2004-04-29
JP4529030B2 (ja) 2010-08-25
EP1551992A2 (de) 2005-07-13
US20110092483A1 (en) 2011-04-21
ATE349550T1 (de) 2007-01-15
AU2003285413A1 (en) 2004-05-04
JP2006502745A (ja) 2006-01-26
ES2279975T3 (es) 2007-09-01
AU2003285413A8 (en) 2004-05-04
CA2502544A1 (fr) 2004-04-29
US20070031821A1 (en) 2007-02-08
FR2846009A1 (fr) 2004-04-23
CA2502544C (fr) 2012-11-20
FR2846009B1 (fr) 2007-10-12
DE60310744T2 (de) 2007-10-11
WO2004035813A3 (fr) 2004-07-15
US20060172337A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
DK1242822T3 (da) Fremgangsmåder til påvisning af amyloidogene proteiner
ATE517638T1 (de) Verfahren und zubereitungen zum verabreichen von therapeutischen und diagnostischen mitteln
DK0741694T3 (da) Phenyleddikesyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling og midler indeholdende disse
CY1108630T1 (el) Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο
TW201129553A (en) Dipeptidyl peptidase inhibitors
NO20071702L (no) Fremgangsmate for fremstilling av 4,5-dihydro-pyrazolo[3,4-C]pyrid-oner
NO20022095L (no) Heterocyklisk substituerte pyrazoloner
DK1082293T3 (da) Formoterol-polymorfer
NO20075077L (no) Fremgangsmate for a forbedre laering og hukommelse i pattedyr
DE60321552D1 (de) Neues verfahren für die diagnose und prognose von malignen erkrankungen
AU2005221582A8 (en) Tissue repair with multipotent cells
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
CY1109339T1 (el) Υποκατεστημενες ενωσεις 1-οξα-3,8-διαζασπειρο[4.5]-δεκαν-2-ονης και η χρησιμοποιηση τους για την παρασκευη φαρμακων
DE602004012758D1 (de) Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung
DE602004010829D1 (de) Adamantan- und azabicyclooctan- und -nonanderivate, verfahren zu deren herstellung und deren verwendung als dpp-iv-inhibitoren
NO20081362L (no) System og fremgangsmate for a gi en sammensatt maling av en blanding som har innblandet gass
NO20072005L (no) Nye heterocykliske amider
DE60310583D1 (de) Verfahren zum nachweis von methicillinresistenten staphylococcus aureus
DE60320784D1 (de) Stände zur modulierung des knochenwachstums
DE60310744D1 (de) Reihentestverfahren auf moleküle mit anti-prionaktivität: kits, methoden und moleküle
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
FR2894594B1 (fr) Test predictif de reponse therapeutique du cancer du sein
WO2007054537A8 (en) Novel bacterium and vaccine
WO2005046581A3 (en) P18 in stem cell manipulations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition